Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2017 Jul 17;16:121. doi: 10.1186/s12943-017-0697-5

Retraction Note to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer

Bethany Perez White 1,#, Mary Ellen Molloy 1,#, Huiping Zhao 1, Yiyun Zhang 2, Debra A Tonetti 1,
PMCID: PMC5513358  PMID: 28716023

Retraction Note

This article [1] has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCα is in fact MCF-7/PKCα. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article’s conclusions. The authors will be given the opportunity to resubmit their corrected data.

Footnotes

The online version of the original article can be found under doi:10.1186/1476-4598-12-34

Reference

  • 1.Perez White B, Molloy ME, Zhao H, Zhang Y, Tonetti DA. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing. Mol Cancer. 2013;12:34. doi: 10.1186/1476-4598-12-34. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES